ARTICLE | Clinical News
Acceleron, Celgene preclinical data
November 19, 2012 8:00 AM UTC
In a mouse model of beta-thalassemia intermedia, ACE-536 significantly increased red blood cell and hemoglobin levels and reduced erythropoietin levels and the size of enlarged spleens vs. controls. F...